BIOMAT Database Logo BIOMAT Database Logo

Kinetic studies with the non-nucleoside human immunodeficiency virus type-1 reverse transcriptase inhibitor U-90152E. 1994

I W Althaus, and J J Chou, and A J Gonzales, and M R Deibel, and K C Chou, and F J Kezdy, and D L Romero, and R C Thomas, and P A Aristoff, and W G Tarpley
Upjohn Company, Kalamazoo, MI 49001.

The bisheteroarylpiperazine U-90152E is a potent inhibitor of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) and possesses excellent anti-HIV activity in HIV-1-infected lymphocytes grown in tissue culture. The compound inhibits both the RNA- and DNA-directed DNA polymerase functions of HIV-1 RT. Kinetic studies were carried out to elucidate the mechanism of RT inhibition by U-90152E. Michaelis-Menten kinetics, which are based on the establishment of a rapid equilibrium between the enzyme and its substrates, proved inadequate for the analysis of the experimental data. The data were thus analyzed using Briggs-Haldane kinetics, assuming that the reaction is ordered in that the template:primer binds to the enzyme first, followed by the addition of dNTP and that the polymerase is a processive enzyme. Based on these assumptions, a velocity equation was derived, which allows the calculation of all the essential forward and backward rate constants for the reactions occurring between the enzyme, its substrates and the inhibitor. The results obtained indicate that U-90152E acts exclusively as a mixed inhibitor with respect to the template: primer and dNTP binding sites for both the RNA- and DNA-directed DNA polymerase domains of the enzyme. The inhibitor shows a significantly higher binding affinity for the enzyme-substrate complexes than for the free enzyme and consequently does not directly impair the functions of the substrate binding sites. Therefore, U-90152E appears to impair an event occurring after the formation of the enzyme-substrate complexes, which involves either inhibition of the phosphoester bond formation or translocation of the enzyme relative to its template:primer following the formation of the ester bond.

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008433 Mathematics The deductive study of shape, quantity, and dependence. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Mathematic
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D012194 RNA-Directed DNA Polymerase An enzyme that synthesizes DNA on an RNA template. It is encoded by the pol gene of retroviruses and by certain retrovirus-like elements. EC 2.7.7.49. DNA Polymerase, RNA-Directed,RNA-Dependent DNA Polymerase,Reverse Transcriptase,RNA Transcriptase,Revertase,DNA Polymerase, RNA Directed,DNA Polymerase, RNA-Dependent,RNA Dependent DNA Polymerase,RNA Directed DNA Polymerase
D013698 Templates, Genetic Macromolecular molds for the synthesis of complementary macromolecules, as in DNA REPLICATION; GENETIC TRANSCRIPTION of DNA to RNA, and GENETIC TRANSLATION of RNA into POLYPEPTIDES. Genetic Template,Genetic Templates,Template, Genetic
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse

Related Publications

I W Althaus, and J J Chou, and A J Gonzales, and M R Deibel, and K C Chou, and F J Kezdy, and D L Romero, and R C Thomas, and P A Aristoff, and W G Tarpley
Enzymatic kinetic studies with the non-nucleoside HIV reverse transcriptase inhibitor U-9843.
December 1992, Experientia,
I W Althaus, and J J Chou, and A J Gonzales, and M R Deibel, and K C Chou, and F J Kezdy, and D L Romero, and R C Thomas, and P A Aristoff, and W G Tarpley
Identification of a Non-Nucleoside Reverse Transcriptase Inhibitor against Human Immunodeficiency Virus-1.
August 2023, ACS infectious diseases,
I W Althaus, and J J Chou, and A J Gonzales, and M R Deibel, and K C Chou, and F J Kezdy, and D L Romero, and R C Thomas, and P A Aristoff, and W G Tarpley
Nucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase.
January 2004, Current topics in medicinal chemistry,
I W Althaus, and J J Chou, and A J Gonzales, and M R Deibel, and K C Chou, and F J Kezdy, and D L Romero, and R C Thomas, and P A Aristoff, and W G Tarpley
The non-nucleoside reverse transcriptase inhibitor efavirenz stimulates replication of human immunodeficiency virus type 1 harboring certain non-nucleoside resistance mutations.
July 2010, Virology,
I W Althaus, and J J Chou, and A J Gonzales, and M R Deibel, and K C Chou, and F J Kezdy, and D L Romero, and R C Thomas, and P A Aristoff, and W G Tarpley
Characterization of human immunodeficiency virus type 1 strains resistant to the non-nucleoside reverse transcriptase inhibitor RD4-2217.
November 1999, Antiviral chemistry & chemotherapy,
I W Althaus, and J J Chou, and A J Gonzales, and M R Deibel, and K C Chou, and F J Kezdy, and D L Romero, and R C Thomas, and P A Aristoff, and W G Tarpley
Anti-human immunodeficiency virus type 1 activities of novel non-nucleoside reverse transcriptase inhibitors.
February 1994, The Journal of antimicrobial chemotherapy,
I W Althaus, and J J Chou, and A J Gonzales, and M R Deibel, and K C Chou, and F J Kezdy, and D L Romero, and R C Thomas, and P A Aristoff, and W G Tarpley
Broad nucleoside reverse-transcriptase inhibitor cross-resistance in human immunodeficiency virus type 1 clinical isolates.
October 2003, The Journal of infectious diseases,
I W Althaus, and J J Chou, and A J Gonzales, and M R Deibel, and K C Chou, and F J Kezdy, and D L Romero, and R C Thomas, and P A Aristoff, and W G Tarpley
Current status of the non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1.
January 2004, Current topics in medicinal chemistry,
I W Althaus, and J J Chou, and A J Gonzales, and M R Deibel, and K C Chou, and F J Kezdy, and D L Romero, and R C Thomas, and P A Aristoff, and W G Tarpley
ATP-dependent removal of nucleoside reverse transcriptase inhibitors by human immunodeficiency virus type 1 reverse transcriptase.
July 2002, Antimicrobial agents and chemotherapy,
I W Althaus, and J J Chou, and A J Gonzales, and M R Deibel, and K C Chou, and F J Kezdy, and D L Romero, and R C Thomas, and P A Aristoff, and W G Tarpley
[Non-nucleoside reverse transcriptase inhibitors of the human immunodeficiency virus].
November 1998, Medicina clinica,
Copied contents to your clipboard!